Oral anticoagulation with rivaroxaban during pregnancy: a case report

Thromb Haemost. 2014 Dec;112(6):1323-4. doi: 10.1160/TH14-04-0393. Epub 2014 Jul 24.

Authors

O Königsbrügge, M Langer, M Hayde, C Ay, I Pabinger¹

Affiliation

¹ Prof. Dr. Ingrid Pabinger, Medical University of Vienna, Department of Medicine I, Clinical Division of Haematology and Haemostaseology, Waehringer Guertel 18-20, A-1090 Vienna, Austria, Tel.: +43 1 40400 44480, Fax: +43 1 40400 40300, E-mail: ingrid.pabinger@meduniwien.ac.at.

PMID: 25055834
DOI: 10.1160/TH14-04-0393

No abstract available

Publication types

Case Reports
Letter

MeSH terms

Administration, Oral
Anticoagulants / administration & dosage*
Anticoagulants / adverse effects
Blood Coagulation / drug effects*
Blood Coagulation Tests
Drug Substitution
Enoxaparin / administration & dosage*
Female
Humans
Infant, Newborn
Live Birth
Male
Morpholines / administration & dosage*
Morpholines / adverse effects
Pregnancy
Pregnancy Complications, Cardiovascular / diagnosis
Pregnancy Complications, Cardiovascular / drug therapy*
Recurrence
Risk Factors
Rivaroxaban
Thiophenes / administration & dosage*
Thiophenes / adverse effects
Treatment Outcome
Venous Thromboembolism / diagnosis
Venous Thromboembolism / drug therapy*
Young Adult

Substances

Anticoagulants
Enoxaparin
Morpholines
Thiophenes
Rivaroxaban